via Harvard Health
Doctors at Queen Mary University of London and Barts Hospital, and Cambridge University Hospital, have led research using a new type of CT scan to light up tiny nodules in a hormone gland and cure high blood pressure by their removal. The nodules are discovered in one-in-twenty people with high blood pressure.
Published today in Nature Medicine, the research solves a 60-year problem of how to detect the hormone producing nodules without a difficult catheter study that is available in only a handful of hospitals, and often fails. The research also found that, when combined with a urine test, the scan detects a group of patients who come off all their blood pressure medicines after treatment.
128 people participated in the study of a new scan after doctors found that their Hypertension (high blood pressure) was caused by a steroid hormone, aldosterone. The scan found that in two thirds of patients with elevated aldosterone secretion, this is coming from a benign nodule in just one of the adrenal glands, which can then be safely removed. The scan uses a very short-acting dose of metomidate, a radioactive dye that sticks only to the aldosterone-producing nodule. The scan was as accurate as the old catheter test, but quick, painless and technically successful in every patient. Until now, the catheter test was unable to predict which patients would be completely cured of hypertension by surgical removal of the gland. By contrast, the combination of a ‘hot nodule’ on the scan and urine steroid test detected 18 of the 24 patients who achieved a normal blood pressure off all their drugs.
The research, conducted on patients at Barts Hospital, Cambridge University Hospital, and Guy’s and St Thomas’s, and Universities of Glasgow and Birmingham, was funded by the National Institute for Health and Care Research (NIHR) and Medical Research Council (MRC) partnership, Barts Charity, and the British Heart Foundation.
Professor Morris Brown, co-senior author of the study and Professor of Endocrine Hypertension at Queen Mary University of London, said: “These aldosterone-producing nodules are very small and easily overlooked on a regular CT scan. When they glow for a few minutes after our injection, they are revealed as the obvious cause of Hypertension, which can often then be cured. Until now, 99% are never diagnosed because of the difficulty and unavailability of tests. Hopefully this is about to change.”
Professor William Drake, co-senior author of the study and Professor of Clinical Endocrinology at Queen Mary University of London, said: “This study was the result of years of hard work and collaboration between centres across the UK. Much of the ‘on the ground’ energy and drive came from the talented research fellows who, in addition to doing this innovative work, gave selflessly of their time and energy during the national pandemic emergency. The future of research in this area is in very safe hands.”
In most people with Hypertension (high blood pressure), the cause is unknown, and the condition requires life-long treatment by drugs. Previous research by the group at Queen Mary University discovered that in 5-10% of people with Hypertension the cause is a gene mutation in the adrenal glands, which results in excessive amounts of the steroid hormone, aldosterone, being produced. Aldosterone causes salt to be retained in the body, driving up the blood pressure. Patients with excessive aldosterone levels in the blood are resistant to treatment with the commonly used drugs for Hypertension, and at increased risk of heart attacks and strokes.
Original Article: Ten-minute scan enables detection and cure of the commonest cause of high blood pressure
More from: Queen Mary University of London | St Bartholomew’s Hospital | University of Cambridge
The Latest Updates from Bing News
Go deeper with Bing News on:
High blood pressure
- LIST: Which Central Va. localities have the highest rates of high blood pressure?
Nearly half of Americans live with high blood pressure, according to the Centers for Disease Control and Prevention. How many Virginians are dealing with this condition and where do they live?
- Could blood pressure be better controlled with new FDA-approved treatment? What to know.
When you think high blood pressure, you probably think heart, but maybe you also should think kidney. A new FDA-approved treatment for high blood pressure targeting the nerves of the ...
- Counties with the highest rates of high blood pressure in Kansas
STACKER- Nearly half of Americans live with high blood pressure. High blood pressure, or hypertension, contributed to nearly 700,000 deaths in 2021 and is a major risk factor for heart disease and ...
- Immune cells play a bigger role in high blood pressure than previously thought, opening doors for new treatments
A review in Nature Reviews Nephrology presents the association between immune cells and the development of hypertension, suggesting potential new therapeutic targets to mitigate the disease by ...
- Counties with the highest rates of high blood pressure in North Carolina
Stacker compiled a list of counties with the highest rates of high blood pressure in North Carolina using data from the Centers for Disease Control and Prevention.
Go deeper with Bing News on:
Hypertension
- Counties with the highest rates of high blood pressure in Ohio
Nearly half of Americans live with high blood pressure. High blood pressure, or hypertension, contributed to nearly 700,000 deaths in 2021 and is a major risk factor for heart disease and stroke.
- Irregular sleep patterns closely related to hypertension among patients with sleep apnea: Study
In a recent study published in the journal of Sleep found the intricate relationship between sleep regularity, obstructive sleep apnea (OSA), and hypertension. This research was conducted on ...
- Common Blood Pressure Drug Increases Lifespan And Slows Aging in Animals
The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years. Previous ...
- JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin ...
- TyG Index may Predicts Severe Coronary Stenosis in patients with H-Type Hypertension with CAD: Study
Researchers have found in a new study that The TyG index is an independent risk factor for the degree of coronary stenosis and a better predictor in patients with H-type hypertension combined ...